-
1Academic Journal
المصدر: Frontiers in Pediatrics, Vol 9 (2021)
مصطلحات موضوعية: pediatric extraordinary daytime urinary frequency, pediatric patients, pollakiuria, bladder and bowel dysfunction, treatment, laxative, Pediatrics, RJ1-570
وصف الملف: electronic resource
-
2
المصدر: Frontiers in Pediatrics, Vol 9 (2021)
Frontiers in Pediatricsمصطلحات موضوعية: medicine.medical_specialty, Constipation, Combination therapy, medicine.medical_treatment, Laxative, Pediatrics, RJ1-570, Lactulose, Internal medicine, medicine, Prospective cohort study, Original Research, Chronic constipation, pediatric patients, treatment, business.industry, Therapeutic effect, pollakiuria, bladder and bowel dysfunction, pediatric extraordinary daytime urinary frequency, laxative, Pediatrics, Perinatology and Child Health, Defecation, medicine.symptom, business, medicine.drug
-
3
المؤلفون: Yan Li (23143), Ying Zhang (40767), Chao Liu (43092), Xiang Li (114679), Qi Zhou (7408), Chao Sun (139686), Lei Zhang (38117)
-
4Electronic Resource
المؤلفون: Heloury Y., Leclair M.-D.
مصطلحات الفهرس: drug release, enuresis/dt [Drug Therapy], feedback system, flushing, human, incontinence, micturition, micturition disorder, neurogenic bowel, overactive bladder/dt [Drug Therapy], pelvic floor muscle training, postvoid residual urine volume, priority journal, review, side effect/si [Side Effect], sphincter, stress incontinence, urinary tract disease, urine incontinence/dt [Drug Therapy], urine incontinence/pc [Prevention], xerostomia/si [Side Effect], alfuzosin/do [Drug Dose], alfuzosin/pd [Pharmacology], alpha adrenergic receptor blocking agent/pd [Pharmacology], botulinum toxin A/dt [Drug Therapy], cholinergic receptor blocking agent/dt [Drug Therapy], cholinergic receptor blocking agent/pd [Pharmacology], cotrimoxazole/cb [Drug Combination], cotrimoxazole/dt [Drug Therapy], methylphenidate, nitrofurantoin/cb [Drug Combination], nitrofurantoin/dt [Drug Therapy], oxybutynin/ae [Adverse Drug Reaction], oxybutynin/cm [Drug Comparison], oxybutynin/pr [Pharmaceutics], oxybutynin/pk [Pharmacokinetics], oxybutynin/pd [Pharmacology], placebo, propiverine/dt [Drug Therapy], tolterodine/cm [Drug Comparison], tolterodine/pr [Pharmaceutics], tolterodine/pk [Pharmacokinetics], tolterodine/pd [Pharmacology], trimethoprim/dt [Drug Therapy], trospium chloride/dt [Drug Therapy], trospium chloride/pd [Pharmacology], unclassified drug, dysfunctional elimination syndrome, extraordinary daytime urinary frequency, hinman syndrome, postvoid dribbling, doxazocin/do [Drug Dose], doxazocin/pd [Pharmacology], giggle incontinence/dt [Drug Therapy], antibiotic prophylaxis, anticholinergic effect, bladder contraction, bladder disease, bladder dysfunction, bladder filling, bladder instability/dt [Drug Therapy], constipation/si [Side Effect], detrusor muscle, disease association, disease severity, drug dose increase, drug efficacy, drug formulation, Review
URL: Click here for full text options
LibKey Link